A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction.

Beta-adrenergic signaling plays an important role in the natural history of dilated cardiomyopathies. Chronic activation of beta-adrenergic receptors (beta1-AR and beta2-AR) during periods of cardiac stress ultimately harms the failing heart by mechanisms that include alterations in gene expression. Here, we show that stimulation of beta-ARs with isoproterenol in neonate rat ventricular myocytes causes a "fetal" response in the relative activities of the human cardiac fetal and/or adult gene promoters that includes repression of the human and rat alpha-myosin heavy chain (alpha-MyHC) promoters with simultaneous activation of the human atrial natriuretic peptide (ANP) and rat beta-MyHC promoters. We also show that the promoter changes correlate with changes in endogenous gene expression as measured by mRNA expression. Furthermore, we show that these changes are specifically mediated by the beta1-AR, but not the beta2-AR, and are independent of alpha1-AR stimulation. We also demonstrate that the fetal gene response is independent of cAMP and protein kinase A, whereas inhibition of Ca2+/calmodulin-dependent protein kinase (CaMK) pathway blocks isoproterenol-mediated fetal gene program induction. Finally, we show that induction of the fetal program is dependent on activation of the L-type Ca2+ channel. We conclude that in neonatal rat cardiac myocytes, agonist-occupied beta1-AR mobilizes Ca2+ stores to activate fetal gene induction through cAMP independent pathways that involve CaMK.

[1]  Guy Salama,et al.  Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.

[2]  Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. , 2005, Biochemical and biophysical research communications.

[3]  C. Long,et al.  Yin Yang 1 represses α-myosin heavy chain gene expression in pathologic cardiac hypertrophy , 2004 .

[4]  B. Harrison,et al.  The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression , 2004, Molecular and Cellular Biology.

[5]  M. Crow,et al.  Sustained &bgr;1-Adrenergic Stimulation Modulates Cardiac Contractility by Ca2+/Calmodulin Kinase Signaling Pathway , 2004 .

[6]  J. Brown,et al.  Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. , 2004, Cardiovascular research.

[7]  M. Anderson Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.

[8]  R. Lefkowitz,et al.  Myocardial β-adrenergic receptor signaling in vivo: insights from transgenic mice , 1996, Journal of Molecular Medicine.

[9]  M. Crow,et al.  Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. , 2004, Circulation research.

[10]  C. Long,et al.  Adrenergic hormones and control of cardiac myocyte growth , 2004, Molecular and Cellular Biochemistry.

[11]  M. Prasad,et al.  Enhanced membrane protein kinase C activity in myocardial ischemia , 2004, Basic Research in Cardiology.

[12]  T. Eschenhagen,et al.  Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase. , 2003, Cardiovascular research.

[13]  C. Long,et al.  Yin Yang 1 Is Increased in Human Heart Failure and Represses the Activity of the Human α-Myosin Heavy Chain Promoter* , 2003, Journal of Biological Chemistry.

[14]  O. Brodde,et al.  Role of β1- and β2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  A. Dart,et al.  Altered calcium transient and development of hypertrophy in β2‐adrenoceptor overexpressing mice with and without pressure overload , 2003, European journal of heart failure.

[16]  B. Kobilka,et al.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.

[17]  O. Brodde,et al.  Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes. , 2003, Naunyn-Schmiedeberg's archives of pharmacology.

[18]  G. Wallukat,et al.  The β-Adrenergic Receptors , 2002, Herz.

[19]  R. Quaife,et al.  Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. , 2002, The New England journal of medicine.

[20]  Michael R. Bristow,et al.  Regulation of Thyroid Hormone Receptor Isoforms in Physiological and Pathological Cardiac Hypertrophy , 2001, Circulation research.

[21]  K. McDonald,et al.  Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. , 2001, American journal of physiology. Heart and circulatory physiology.

[22]  Y. Kihara,et al.  Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure , 2001, Circulation.

[23]  Rick B. Vega,et al.  Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Vatner,et al.  β-adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart , 2001 .

[25]  S. Vatner,et al.  Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. , 2001, Journal of molecular and cellular cardiology.

[26]  Y. Zou,et al.  Ca2+/Calmodulin-dependent Kinase II and Calcineurin Play Critical Roles in Endothelin-1-induced Cardiomyocyte Hypertrophy* , 2000, The Journal of Biological Chemistry.

[27]  R. Devereux,et al.  Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.

[28]  H. Cantiello,et al.  Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Leinwand,et al.  Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. , 1998, Circulation research.

[30]  G. Jennings,et al.  Adrenergic nervous system in heart failure. , 1997, The American journal of cardiology.

[31]  M. Bristow Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.

[32]  M. Bristow,et al.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.

[33]  C. Long,et al.  Interleukin-1β Is a Negative Transcriptional Regulator of α1-Adrenergic Induced Gene Expression in Cultured Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.

[34]  A. Clerk,et al.  Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. , 1996, The Biochemical journal.

[35]  C. Long,et al.  Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. , 1996, The Journal of biological chemistry.

[36]  R. Lefkowitz,et al.  Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice. , 1996, Journal of molecular medicine.

[37]  E. Lakatta,et al.  Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. , 1995, The American journal of physiology.

[38]  B. Wollnik,et al.  Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth. , 1995, European heart journal.

[39]  C. Glembotski,et al.  Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin. , 1994, The Journal of biological chemistry.

[40]  C. Long,et al.  Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. , 1993, Journal of molecular and cellular cardiology.

[41]  S. Goldstein,et al.  Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. , 1992, Journal of the American College of Cardiology.

[42]  C. Long,et al.  Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy. , 1992, Basic research in cardiology.

[43]  C. Long,et al.  A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. , 1991, Cell regulation.

[44]  D. Atlas,et al.  The Metabotropic Glutamate Receptors , 1994, The Receptors.

[45]  P. Simpson,et al.  The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. , 1990, The Journal of clinical investigation.

[46]  P. Simpson,et al.  Myocyte Hypertrophy in Neonatal Rat Heart Cultures and Its Regulation by Serum and by Catecholamines , 1982, Circulation research.

[47]  P. Simpson,et al.  Differentiation of Rat Myocytes in Single Cell Cultures with and without Proliferating Nonmyocardial Cells: Cross‐Striations, infrastructure, and Chronotropic Response to Isoproterenol , 1982, Circulation research.

[48]  B. Swynghedauw,et al.  Myosin isoenzyme redistribution in chronic heart overload , 1979, Nature.

[49]  B MAYNE,et al.  On aortic regurgitation , 1953, Irish journal of medical science.